Le Lézard
Classified in: Health
Subjects: OFR, PVP

Select Medical Corporation Closes Private Placement of $675 Million of 6.250% Senior Notes due 2026

MECHANICSBURG, Pa., Dec. 10, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") has completed its private placement of $675 million aggregate principal amount of its 6.250% Senior Notes due 2026 as additional notes (the "Additional Notes") under same indenture as Select's existing $550 million aggregate principal amount of 6.250% senior notes due 2026 that were originally issued on August 1, 2019 and, as such, will form a single series and trade interchangeably with such previously issued notes.

Selects intends to use a portion of the net proceeds of this offering, together with a portion of the net proceeds from a $615 million incremental term loan and, if required, available cash, to loan to its joint venture subsidiary, Concentra, Inc. ("Concentra"), pursuant to the terms of an intercompany loan agreement, an amount which will be used by Concentra to repay in full all currently outstanding term loan indebtedness under Concentra's first lien credit agreement. Any remaining net proceeds from the offering will be used by Select for general corporate purposes.

The notes and related guarantees were sold in a private placement, solely to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), or outside the United States to persons other than "U.S. persons" in compliance with Regulation S under the Securities Act. The notes and related guarantees have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

This notice does not constitute an offer to sell the notes, nor a solicitation for an offer to purchase the notes, in any jurisdiction in which such offer or solicitation would be unlawful. Any offer of the notes will be made only by means of a private offering memorandum. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act.

Investor inquiries:
Joel T. Veit
Senior Vice President and Treasurer

SOURCE Select Medical Holdings Corporation

These press releases may also interest you

at 22:53
Today, the U.S. Food and Drug Administration issued the final guidance, "Breast Implants - Certain Labeling Recommendations to Improve Patient Communication," as part of the agency's effort to help improve the information available to patients and...

at 22:00
The Global Health Innovative Technology (GHIT) Fund announced today a total of 1.37 billion yen (US$13 million*) to invest in seven partnerships to develop new lifesaving drugs and diagnostics for malaria, Buruli ulcer, Chagas disease, leishmaniasis,...

at 21:58
Government of Canada officials will hold a technical briefing to provide an overview on the authorization of coronavirus testing applications and devices (COVID-19). DateSeptember 29, 2020 Time10:30 AM (EDT) LocationMedia Technical Briefing will be...

at 20:27
Catracho, the COVID-19 treatment method Honduras is using to save lives, was one of the 150 formulas chosen from 30,000 ones presented at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Conference on Coronavirus, with...

at 19:14
In the world of women's beauty today, there is no doubt that the arms are a major focus of attention. From social media to "best of" lists, the sexy look of  celebrities' slim, toned and contoured arms are highly sought after and seen as a "must...

at 19:14
Today the Accreditation Council for Graduate Medical Education (ACGME) released its 2019-2020 Data Resource Book, the most comprehensive and reliable resource of its kind, including data on the size, scope, and distribution of graduate medical...

News published on 10 december 2019 at 16:15 and distributed by: